September 27th 2023
Ryzumi is expected to be available in the first half of 2024. Pricing will be available around the time of launch.
September 22nd 2023
Top 15 Potential Blockbuster Drugs to Watch
January 10th 2023Clarivate analysts have identified the treatments they forecast could deliver annual sales of more than $1 billion within five years. These include therapies for rare diseases, as well as HIV, Parkinson’s disease, Crohn’s disease, alopecia, and cancer.
Best Read Drug Approvals Stories in 2022
December 26th 2022Among the top-read FDA approval stories include the fast-acting Auvelity to treat major depressive disorder; an extended use for Mirena IUD; the first generic of Symbicort for asthma; Camzyos, a first-in-class treatment for obstructive hypertrophic cardiomyopathy; and Imbruvica’s expanded indication for children with chronic graft versus host disease.